217 related articles for article (PubMed ID: 1154379)
21. Pancreatic compartmentalization of insulin. Evidence for pituitary control.
Merimee TJ; Fineberg SE
Diabetes; 1973 Jan; 22(1):25-9. PubMed ID: 4683793
[No Abstract] [Full Text] [Related]
22. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
[TBL] [Abstract][Full Text] [Related]
23. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
Haupt E; Beyer J; Schöffling K
Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
[No Abstract] [Full Text] [Related]
24. Effect of tolbutamide on plasma catecholamine in insulin dependent diabetics.
Sato T; Miura Y; Saito T; Ito M; Kokubun M; Sakuma H; Adachi M; Yoshinaga K
Tohoku J Exp Med; 1979 Jan; 127(1):97-8. PubMed ID: 760255
[TBL] [Abstract][Full Text] [Related]
25. [Plasma insulin levels in endocrine diseases. I. Plasma insulin levels in normal subjects and diabetic patients].
Ikeda M
Nihon Naibunpi Gakkai Zasshi; 1971 Aug; 47(5):282-90. PubMed ID: 5106320
[No Abstract] [Full Text] [Related]
26. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.
Sagen JV; Pearson ER; Johansen A; Spyer G; Søvik O; Pedersen O; Njølstad PR; Hattersley AT; Hansen T
Diabet Med; 2005 Apr; 22(4):406-9. PubMed ID: 15787664
[TBL] [Abstract][Full Text] [Related]
27. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
Mokuda O; Murakami I; Ikeda T; Tominaga M; Mashiba H
Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183
[TBL] [Abstract][Full Text] [Related]
28. [The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
Bigelow-Sherman JD; Shima K; Borden EK; Foà PP; Penhallegon R
Acta Diabetol Lat; 1970; 7(1):68-92. PubMed ID: 5493440
[No Abstract] [Full Text] [Related]
29. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance.
Hinds A; Sheehan AG; Parsons HG
Metabolism; 1995 Jan; 44(1):13-8. PubMed ID: 7854158
[TBL] [Abstract][Full Text] [Related]
30. Insulin response to secretogogues in sheep exposed to cold.
Sasaki Y; Takahashi H
J Physiol; 1983 Jan; 334():155-67. PubMed ID: 6345757
[TBL] [Abstract][Full Text] [Related]
31. Insulin secretion in insulin-requiring diabetics before and during insulin treatment.
Enk B
Acta Endocrinol (Copenh); 1977 Jul; 85(3):559-70. PubMed ID: 577340
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of intravenous glucagon test in insulinoma.
Oneda A; Maruhama Y; Itabashi H; Horigome K; Yanbe A
Tohoku J Exp Med; 1975 Jul; 116(3):205-11. PubMed ID: 170711
[TBL] [Abstract][Full Text] [Related]
33. [Maximum stimulation test of beta cells of the pancreas (glucose + tolbutamide + glucagon) in healthy non-alcoholic subjects].
Peña Yáñez A; López Luque A; Osorio J; Requena F; Palomo S
Rev Clin Esp; 1978 Jul; 150(1-2):43-8. PubMed ID: 360320
[No Abstract] [Full Text] [Related]
34. [Effects of increasing doses of tolbutamide on insulin secretion in normal and diabetic subjects].
Ragonese F; Carducci Artenisio A; Alibrando A; Martelli G; Forte F; Consolo F
Boll Soc Ital Biol Sper; 1978 Oct; 54(20):1978-84. PubMed ID: 753287
[No Abstract] [Full Text] [Related]
35. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
[TBL] [Abstract][Full Text] [Related]
36. Diabetes mellitus in gonadal dysgenesis: studies of insulin and growth hormone secretion.
Rasio E; Antaki A; Van Campenhout J
Eur J Clin Invest; 1976 Jan; 6(1):59-66. PubMed ID: 1253808
[TBL] [Abstract][Full Text] [Related]
37. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
Devrim S; Koniçe M; Sencer E; Molvalìlar S; Alp H
Isr J Med Sci; 1972 Jun; 8(6):815-20. PubMed ID: 5051802
[No Abstract] [Full Text] [Related]
38. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
Vague P; Ramahandridona G; Gerolami A
Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
[No Abstract] [Full Text] [Related]
39. Insulin response to glucagon. The opposing effects of diabetes and obesity.
Crockford PM; Hazzard WR; Williams RH
Diabetes; 1969 Apr; 18(4):216-24. PubMed ID: 5776458
[No Abstract] [Full Text] [Related]
40. Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics.
Volpi R; Chiodera P; Capretti L; Caffarri G; Giuliani N; Caiazza A; Coiro V
J Intern Med; 1998 Jul; 244(1):43-8. PubMed ID: 9698023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
